HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,462,857 | -0.5% | 133,657 | -11.5% | 0.03% | +3.3% |
Q2 2023 | $15,536,107 | -65.4% | 151,056 | -63.3% | 0.03% | -65.9% |
Q1 2023 | $44,891,407 | -16.0% | 411,319 | -12.4% | 0.09% | -20.0% |
Q4 2022 | $53,437,633 | +62.4% | 469,575 | -11.7% | 0.11% | +52.8% |
Q3 2022 | $32,902,000 | +245.6% | 531,655 | +345.6% | 0.07% | +278.9% |
Q2 2022 | $9,519,000 | -31.7% | 119,301 | -9.8% | 0.02% | -20.8% |
Q1 2022 | $13,929,000 | -2.8% | 132,291 | -0.5% | 0.02% | +4.3% |
Q4 2021 | $14,333,000 | -6.6% | 132,978 | -5.1% | 0.02% | -11.5% |
Q3 2021 | $15,349,000 | +31.6% | 140,106 | +12.5% | 0.03% | +30.0% |
Q2 2021 | $11,665,000 | +67.1% | 124,516 | +63.8% | 0.02% | +66.7% |
Q1 2021 | $6,982,000 | +79.8% | 76,011 | +42.9% | 0.01% | +50.0% |
Q4 2020 | $3,883,000 | -39.7% | 53,186 | -35.9% | 0.01% | -42.9% |
Q3 2020 | $6,442,000 | +35.6% | 82,943 | -3.0% | 0.01% | +27.3% |
Q2 2020 | $4,752,000 | -7.8% | 85,548 | -50.9% | 0.01% | -15.4% |
Q1 2020 | $5,155,000 | -70.6% | 174,373 | -64.1% | 0.01% | -60.6% |
Q4 2019 | $17,551,000 | -10.7% | 485,216 | -32.6% | 0.03% | -13.2% |
Q3 2019 | $19,664,000 | +476.5% | 720,092 | +408.0% | 0.04% | +533.3% |
Q2 2019 | $3,411,000 | – | 141,763 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |